Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines. 2002

Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
Department of Hygiene-Chemistry, Faculty of Pharmaceutical Sciences, Science University of Tokyo, Japan.

In a previous study, we found that TPA-mediated up-regulation of p21(WAF1/CIP1) induces growth arrest and differentiation of the human prostate cancer cell line TSU-Pr1. We investigated the effect of 12-O-tetra-decanoylphorbol-13-acetate (TPA) on growth and p21(WAF1/CIP1) protein levels in four prostate cancer cell lines. TPA treatment suppressed proliferation of the androgen-insensitive prostate cancer cell lines DU145 and PC-3. DU145 and PC-3 cells, however, showed neither morphological changes nor differentiation after TPA treatment. In contrast, TPA induced apoptosis of the androgen-sensitive prostate cancer cell line LNCaP. TPA induced up-regulation of p21(WAF1/CIP1) protein levels in all four cancer cell lines and this up-regulation was regulated by PKC in all four, but MAP kinase was associated with regulation only in TSU-Pr1 cells. Moreover, transient transfection with Adv-p21 resulted in growth arrest of all four cell lines. These data suggest that increased p21(WAF1/CIP1) production directly suppresses proliferation of prostate cancer cells regardless of androgen sensitivity. The pathway of TPA-induced increases in p21(WAF1/CIP1) levels was regulated by PKC. We thus conclude that p21(WAF1/CIP1) is a good candidate for use in treatment of prostate cancers because it suppresses proliferation of several prostate cancer cell lines.

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation

Related Publications

Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
July 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
January 2003, Cancer letters,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
March 2003, Journal of biochemistry and molecular biology,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
January 2010, PloS one,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
June 1996, International journal of oncology,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
February 1999, Experimental cell research,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
December 2014, FEBS letters,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
January 1998, Progress in molecular and subcellular biology,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
March 2004, Cardiovascular research,
Ryo Sugibayashi, and Yoko Kiguchi, and Takahisa Shimizu, and Toshihiro Suzuki, and Hirofumi Hamada, and Ken Takeda
April 2002, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!